0000899243-19-027661.txt : 20191120 0000899243-19-027661.hdr.sgml : 20191120 20191120121154 ACCESSION NUMBER: 0000899243-19-027661 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191113 FILED AS OF DATE: 20191120 DATE AS OF CHANGE: 20191120 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Eastwood Craig S. CENTRAL INDEX KEY: 0001701834 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-49908 FILM NUMBER: 191233504 MAIL ADDRESS: STREET 1: 1111 MAIN STREET, SUITE 660 CITY: VANCOUVER STATE: WA ZIP: 98660 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CytoDyn Inc. CENTRAL INDEX KEY: 0001175680 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 753056237 STATE OF INCORPORATION: DE FISCAL YEAR END: 0531 BUSINESS ADDRESS: STREET 1: 1111 MAIN STREET, SUITE 660 CITY: VANCOUVER STATE: WA ZIP: 98660 BUSINESS PHONE: 360-980-8524 MAIL ADDRESS: STREET 1: 1111 MAIN STREET, SUITE 660 CITY: VANCOUVER STATE: WA ZIP: 98660 FORMER COMPANY: FORMER CONFORMED NAME: CYTODYN INC DATE OF NAME CHANGE: 20031114 FORMER COMPANY: FORMER CONFORMED NAME: REXRAY CORP DATE OF NAME CHANGE: 20020617 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2019-11-13 0 0001175680 CytoDyn Inc. CYDY 0001701834 Eastwood Craig S. 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 0 1 0 0 Chief Financial Officer Common Stock 0 D Stock Option (Right to Buy) 0.50 2029-04-29 Common Stock 100000 D Stock Option (Right to Buy) 0.52 2029-06-18 Common Stock 100000 D The options will vest in three equal annual installments commencing on April 29, 2020. The options will vest in three equal annual installments commencing on June 18, 2020. /s/ Craig S. Eastwood 2019-11-19